 |
 |

Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy: Heart and Estrogen/Progestin Replacement Study Follow-up (HERS II)Correction
JAMA. 2002;288:1064.
Numbers Reversed. In the Original Contribution entitled "Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy: Heart and Estrogen/Progestin Replacement Study Follow-up (HERS II)" published in the July 3, 2002, issue of THE JOURNAL (2002;288:49-57), 2 numbers were reversed. On page 53, the fourth sentence in the "Adjusted and per Protocol Analyses" section should read "By the end of follow-up in HERS II, the proportion of statin use was 63% for the hormone group and 67% for the placebo group (P = .01)."
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|